MIK665 (S64315)

目录号:S8836 批次号:S883602

打印

化学数据

化学结构式 别名 N/A 储存条件
(自收到货起)
3年 -20°C 粉状
化学式

C47H44ClFN6O6S

分子量 875.41 CAS号 1799631-75-6
Solubility (25°C)* 体外 DMSO 100 mg/mL (114.23 mM)
Water Insoluble
Ethanol Insoluble
体内
(现配现用)
均匀悬浊液
CMC-NA
≥5mg/ml 以 1 mL 工作液为例,取 5 mg该产品加到 1 ml CMC-NA 溶液中,混合均匀,即可得工作液浓度为 5 mg/ml的均匀悬浊液。
澄清溶液
5%DMSO 40%PEG300 5%Tween80 50%ddH2O

该配方已经过Selleck实验室实测。如果上述溶解方案不能满足您的需求,可联系Selleck销售提供定制化测试。

5.000mg/ml (5.71mM) 以 1 mL 工作液为例,取50μL100mg/ml的澄清DMSO储备液加到 400μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入500μL ddH2O定容至 1 mL。工作液请现配现用!
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

制备储备液

生物活性

产品描述 MIK665 (S64315)是Mcl的抑制剂,Ki值为1.2 nM。它具有潜在的促凋亡和抗肿瘤活性。
靶点
Mcl-1
(Cell-free assay)
1.2 nM(Ki)

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

MIK665 (S64315)在文献中得到引用

The tubulin polymerization inhibitor gambogenic acid induces myelodysplastic syndrome cell apoptosis through upregulation of Fas expression mediated by the NF-κB signaling pathway [ Cancer Biology & Therapy, November 14, 2024, 2427374] PubMed: 39540618
Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models [ Blood Advances, March 10, 2020, 819-829]
Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies [ Haematologica, June 19, 2025, 2974-2985] PubMed: 40534489
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells [ Cell Death & Disease, June 08, 2020, 443] PubMed: 32513939
Inhibition of BCL-2 and MCL-1 disrupts mitochondrial respiration and overcomes radioresistance in choroidal melanoma [ Biochem Biophys Res Commun, 2025, 784:152650] PubMed: 40983007
Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy [ Nature Communications, 2024, 1581] PubMed: 38383524.0
Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy [ Nat Commun, 2024, 15(1):1581] PubMed: 38383524
The tubulin polymerization inhibitor gambogenic acid induces myelodysplastic syndrome cell apoptosis through upregulation of Fas expression mediated by the NF-κB signaling pathway [ Cancer Biology & Therapy, 2024, 2427374] PubMed: 39540618.0
The tubulin polymerization inhibitor gambogenic acid induces myelodysplastic syndrome cell apoptosis through upregulation of Fas expression mediated by the NF-κB signaling pathway [ Cancer Biol Ther, 2024, 25(1):2427374] PubMed: 39540618
Targeting MCL-1 triggers DNA damage and an anti-proliferative response independent from apoptosis induction [ Cell Rep, 2023, 42(10):113176] PubMed: 37773750

特定的存储和包装每个产品的信息在产品说明书上都有注明。大多数Selleck产品,在推荐的条件下存储可稳定保存两年。产品有时建议的储存温度不同,大多数建议储存在-20°C,抑制剂属于化学试剂,可在常温下运输储存两周左右。即使如此,我们保证产品的出货量将保持产品质量的条件下,一般都会放入冰袋。望阁下收到产品后,请按照产品数据表建议适当存储。

如果需要长期保存,请于零下二十度低温保存。禁止用于人体及治疗!

退换货政策

Selleck提供宽松的退换货承诺,努力为您营造最优的购物体验。每个订单Selleck只提供一次退换货服务,为了确保您的权益,请您仔细阅读以下内容:

1. 请在返还样品之前事先与我们取得联系,以确保产品是直接向我们或者当地代理商购买的;

2. 自收到货物起七天内,如因运输过程有问题或其他任何问题,您可以提出退换货要求;自收到货物起365天内,如因产品质量有问题,您可以提出退换货要求。

3. 请使用我们的快递账号进行退换货,您无需为此承担任何费用。

4. 如您已收到由Selleck开具的发票,则办理退货或订单金额发生变更的换货时,请将发票随商品一同返还给Selleck。请您妥善保管发票,如发票丢失,将无法办理退换货手续。

5. 对于合理的退换货要求,我们会在5个工作日内处理完成您的款项退还和新换货物的运输等,请耐心等待。